Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1954 3
1955 2
1956 2
1957 1
1958 1
1959 2
1960 1
1961 5
1962 7
1963 11
1964 15
1965 4
1966 12
1967 19
1968 15
1969 6
1970 20
1971 16
1972 21
1973 21
1974 32
1975 20
1976 20
1977 30
1978 33
1979 24
1980 26
1981 41
1982 70
1983 59
1984 62
1985 64
1986 78
1987 86
1988 74
1989 103
1990 106
1991 119
1992 147
1993 163
1994 118
1995 127
1996 155
1997 160
1998 177
1999 148
2000 171
2001 141
2002 160
2003 174
2004 191
2005 219
2006 216
2007 231
2008 275
2009 271
2010 293
2011 315
2012 308
2013 320
2014 334
2015 369
2016 375
2017 404
2018 407
2019 406
2020 450
2021 476
2022 450
2023 397
2024 121

Text availability

Article attribute

Article type

Publication date

Search Results

8,953 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
Yamaguchi TP, Willert K. Yamaguchi TP, et al. Curr Top Dev Biol. 2023;153:xv-xvi. doi: 10.1016/S0070-2153(23)00054-6. Curr Top Dev Biol. 2023. PMID: 36967204 No abstract available.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Among authors: yamaguchi t. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
Clinical Guidelines for Diagnosis and Management of Peutz-Jeghers Syndrome in Children and Adults.
Yamamoto H, Sakamoto H, Kumagai H, Abe T, Ishiguro S, Uchida K, Kawasaki Y, Saida Y, Sano Y, Takeuchi Y, Tajika M, Nakajima T, Banno K, Funasaka Y, Hori S, Yamaguchi T, Yoshida T, Ishikawa H, Iwama T, Okazaki Y, Saito Y, Matsuura N, Mutoh M, Tomita N, Akiyama T, Yamamoto T, Ishida H, Nakayama Y. Yamamoto H, et al. Among authors: yamaguchi t. Digestion. 2023;104(5):335-347. doi: 10.1159/000529799. Epub 2023 Apr 13. Digestion. 2023. PMID: 37054692 Free article. Review.
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.
Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y, Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon DA, Chang SM, Hervey-Jumper SL, Berger MS, Lupo JM, Okada H, Phillips JJ, Boutros PC, Gallo M, Oldham MC, Yue F, Costello JF. Mathur R, et al. Among authors: yamaguchi tn. Cell. 2024 Jan 18;187(2):446-463.e16. doi: 10.1016/j.cell.2023.12.013. Cell. 2024. PMID: 38242087
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM, Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G. Nassiri F, et al. Among authors: yamaguchi tn. Nat Med. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. Epub 2023 May 15. Nat Med. 2023. PMID: 37188783 Free PMC article. Clinical Trial.
Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study).
Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Mashiko T, Horikoshi M, Furukawa TA, Yoshimura A, Ohno S, Uehiro N, Higaki K, Hasegawa Y, Akahane K, Uchitomi Y, Iwata H. Akechi T, et al. Among authors: yamaguchi t. J Clin Oncol. 2023 Feb 10;41(5):1069-1078. doi: 10.1200/JCO.22.00699. Epub 2022 Nov 2. J Clin Oncol. 2023. PMID: 36322882 Free PMC article. Clinical Trial.
A consideration of cross-disciplinary collaboration.
Yamaguchi T. Yamaguchi T. J Med Ultrason (2001). 2023 Apr;50(2):119. doi: 10.1007/s10396-023-01303-0. Epub 2023 May 12. J Med Ultrason (2001). 2023. PMID: 37171736 No abstract available.
Response to Letter to Editor.
Takahashi R, Yabe H, Hibino T, Yamaguchi T, Morishita S, Kono K, Moriyama Y, Yamada T. Takahashi R, et al. Among authors: yamaguchi t. J Ren Nutr. 2023 Jul;33(4):611-613. doi: 10.1053/j.jrn.2023.03.002. Epub 2023 Mar 23. J Ren Nutr. 2023. PMID: 36963737 No abstract available.
A polygenic two-hit hypothesis for prostate cancer.
Houlahan KE, Livingstone J, Fox NS, Kurganovs N, Zhu H, Sietsma Penington J, Jung CH, Yamaguchi TN, Heisler LE, Jovelin R, Costello AJ, Pope BJ, Kishan AU, Corcoran NM, Bristow RG, Waszak SM, Weischenfeldt J, He HH, Hung RJ, Hovens CM, Boutros PC. Houlahan KE, et al. Among authors: yamaguchi tn. J Natl Cancer Inst. 2023 Apr 11;115(4):468-472. doi: 10.1093/jnci/djad001. J Natl Cancer Inst. 2023. PMID: 36610996 Free PMC article.
8,953 results